C4 THERAPEUTICS INC. - COMMON STOCK
4.2500
22-11月-24 15:44:58
15 分の遅延
株式
+0.2400
+5.99%
本日の幅
3.9100 - 4.3385
ISIN
N/A
ソース
NASDAQ
-
C4 Therapeutics to Participate in the Stifel 2024 Targeted Oncology Forum
09 4 2024 06:00:00 提供 Nasdaq GlobeNewswire
-
05 3 2024 15:30:00 提供 Nasdaq GlobeNewswire
-
04 3 2024 06:00:00 提供 Nasdaq GlobeNewswire
-
22 2 2024 06:00:00 提供 Nasdaq GlobeNewswire
-
09 1 2024 15:01:00 提供 Nasdaq GlobeNewswire
-
C4 Therapeutics Announces Closing of $25 Million Equity Investment by Betta Pharmaceuticals
04 1 2024 15:01:00 提供 Nasdaq GlobeNewswire
-
C4 Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
04 1 2024 06:00:00 提供 Nasdaq GlobeNewswire
-
12 12 2023 15:01:00 提供 Nasdaq GlobeNewswire
-
12 12 2023 06:00:00 提供 Nasdaq GlobeNewswire
-
28 11 2023 06:00:00 提供 Nasdaq GlobeNewswire
-
C4 Therapeutics Strengthens Board of Directors with Owen Hughes Appointment
20 11 2023 06:00:00 提供 Nasdaq GlobeNewswire
-
C4 Therapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights
01 11 2023 06:00:00 提供 Nasdaq GlobeNewswire
-
11 10 2023 06:00:00 提供 Nasdaq GlobeNewswire
-
C4 Therapeutics Announces Chief Financial Officer Succession
05 9 2023 15:01:00 提供 Nasdaq GlobeNewswire
-
C4 Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights
08 8 2023 06:00:01 提供 Nasdaq GlobeNewswire
-
C4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
17 7 2023 06:00:00 提供 Nasdaq GlobeNewswire
-
C4 Therapeutics Appoints Leonard Reyno, M.D., as Chief Medical Officer
20 6 2023 06:00:00 提供 Nasdaq GlobeNewswire